Trial Outcomes & Findings for Micro-osteoperforations and Tooth Movement (NCT NCT02473471)
NCT ID: NCT02473471
Last Updated: 2017-11-28
Results Overview
The baseline 3D digital model was superimposed to 3D digital models of the 1st month to determine the anterioposterior displacement of canines.
COMPLETED
NA
35 participants
Baseline to 1st month
2017-11-28
Participant Flow
Participants recruited from a postgraduate clinic at Jordanian University of Science and Technology, in Irbid city, Jordan between Aug 2015 and Jan 2016.
Participant milestones
| Measure |
All Study Participants
Split-mouth design study in which the intervention (MOP Side) was randomly assigned to either right or the left side in the maxillary arch where other side serves as a control.
Randomization was accomplished with block randomization with a permuted block size of 2 with 1:1 allocation ratio to either right or left with allocations concealed in opaque, sealed envelopes. Blinding was applicable at data collection and analysis stage.
|
|---|---|
|
Overall Study
STARTED
|
35
|
|
Overall Study
Received Allocated Intervention
|
33
|
|
Overall Study
Randomized Not Treated
|
2
|
|
Overall Study
COMPLETED
|
32
|
|
Overall Study
NOT COMPLETED
|
3
|
Reasons for withdrawal
| Measure |
All Study Participants
Split-mouth design study in which the intervention (MOP Side) was randomly assigned to either right or the left side in the maxillary arch where other side serves as a control.
Randomization was accomplished with block randomization with a permuted block size of 2 with 1:1 allocation ratio to either right or left with allocations concealed in opaque, sealed envelopes. Blinding was applicable at data collection and analysis stage.
|
|---|---|
|
Overall Study
poor oral hygiene
|
2
|
|
Overall Study
Lost to Follow-up
|
1
|
Baseline Characteristics
Micro-osteoperforations and Tooth Movement
Baseline characteristics by cohort
| Measure |
All Study Participants
n=35 Participants
Includes groups randomized to receive MOP intervention on one side while the other side serve as control side.
|
|---|---|
|
Age, Continuous
|
19.26 years
STANDARD_DEVIATION 2.48 • n=5 Participants
|
|
Sex: Female, Male
Female
|
25 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
10 Participants
n=5 Participants
|
|
Region of Enrollment
Jordan
|
35 participants
n=5 Participants
|
|
Sella-Nasion to A Point Angle (SNA)
|
81.9 Degree
STANDARD_DEVIATION 4.07 • n=5 Participants
|
|
Sella-Nasion to B Point Angle (SNB)
|
76.5 Degree
STANDARD_DEVIATION 3.85 • n=5 Participants
|
|
A point to B Point Angle (ANB)
|
5.5 Degree
STANDARD_DEVIATION 2.69 • n=5 Participants
|
|
Maxillary mandibular plane angle
|
28.9 Degree
STANDARD_DEVIATION 4.27 • n=5 Participants
|
|
Lower anterior facial height(LAFH)
|
55.67 mm
STANDARD_DEVIATION 1.81 • n=5 Participants
|
|
Upper incisor inclination
|
119.94 Degree
STANDARD_DEVIATION 7.53 • n=5 Participants
|
PRIMARY outcome
Timeframe: Baseline to 1st monthPopulation: Thirty-five subjects were randomized to receive MOP to either right or left sides with 1:1 allocation ratio. Three impressions were missing at first month due to alginate distortion.
The baseline 3D digital model was superimposed to 3D digital models of the 1st month to determine the anterioposterior displacement of canines.
Outcome measures
| Measure |
MOP Side
n=29 Participants
The Micro-osteoperforation side (The Intervention side)
|
Control Side
n=29 Participants
Non intervention side
|
|---|---|---|
|
3D Digital Model Measurements of Canine Rate of Tooth Movement
|
0.65 mm
Standard Deviation 0.26
|
0.67 mm
Standard Deviation 0.34
|
PRIMARY outcome
Timeframe: Baseline to 2nd monthPopulation: Thirty-five subjects were randomized to receive MOP to either right or left sides with 1:1 allocation ratio. only one impression was lost to be taken by a clinician at two months period.
The baseline 3D digital model was superimposed to 3D digital models of 2nd month to determine the anterioposterior displacement of canines.
Outcome measures
| Measure |
MOP Side
n=31 Participants
The Micro-osteoperforation side (The Intervention side)
|
Control Side
n=31 Participants
Non intervention side
|
|---|---|---|
|
3D Digital Model Measurements of Canine Rate of Tooth Movement
|
1.36 mm
Standard Deviation 0.49
|
1.28 mm
Standard Deviation 0.50
|
PRIMARY outcome
Timeframe: Baseline to 3rd monthPopulation: Thirty-five subjects were randomized to receive MOP to either right or left sides with 1:1 allocation ratio. Three impressions were missing at first month due to alginate distortion, and only one impression was lost to be taken by a clinician at two months.
The baseline 3D digital model was superimposed to 3D digital models of 3rd month to determine the anterioposterior displacement of canines.
Outcome measures
| Measure |
MOP Side
n=32 Participants
The Micro-osteoperforation side (The Intervention side)
|
Control Side
n=32 Participants
Non intervention side
|
|---|---|---|
|
3D Digital Model Measurements of Canine Rate of Tooth Movement
|
1.93 mm
Standard Deviation 0.74
|
1.88 mm
Standard Deviation 0.67
|
PRIMARY outcome
Timeframe: Baseline to 1st monthPopulation: 32 subjects were analyzed to receive MOP to either right or left sides. Only one patient was lost to follow up at the first month time point.
Direct intraoral measurement of the distance between canine and second premolar in the patient's mouth was done every week using a digital caliper, from the upper mesial wing of the canine bracket to upper distal wing of second premolar bracket in both right and left sides parallel to the occlusal plane for 3 months.
Outcome measures
| Measure |
MOP Side
n=31 Participants
The Micro-osteoperforation side (The Intervention side)
|
Control Side
n=31 Participants
Non intervention side
|
|---|---|---|
|
Intra Oral Measurements of Canine Rate of Tooth Movement
|
1.23 mm
Standard Deviation 0.45
|
1.17 mm
Standard Deviation 0.42
|
PRIMARY outcome
Timeframe: Baseline to 2nd monthPopulation: 32 subjects were analyzed to receive MOP to either right or left sides.
Direct intraoral measurement of the distance between canine and second premolar in the patient's mouth was done every week using a digital caliper, from the upper mesial wing of the canine bracket to upper distal wing of second premolar bracket in both right and left sides parallel to the occlusal plane for 3 months.
Outcome measures
| Measure |
MOP Side
n=32 Participants
The Micro-osteoperforation side (The Intervention side)
|
Control Side
n=32 Participants
Non intervention side
|
|---|---|---|
|
Intra Oral Measurements of Canine Rate of Tooth Movement
|
2.27 mm
Standard Deviation 0.72
|
2.24 mm
Standard Deviation 0.63
|
PRIMARY outcome
Timeframe: Baseline to 3 monthPopulation: 32 subjects were analyzed who received MOP to either right or left sides.
Direct intraoral measurement of the distance between canine and second premolar in the patient's mouth was done every week using a digital caliper, from the upper mesial wing of the canine bracket to upper distal wing of second premolar bracket in both right and left sides parallel to the occlusal plane for 3 months.
Outcome measures
| Measure |
MOP Side
n=32 Participants
The Micro-osteoperforation side (The Intervention side)
|
Control Side
n=32 Participants
Non intervention side
|
|---|---|---|
|
Intra Oral Measurements of Canine Rate of Tooth Movement
|
3.18 mm
Standard Deviation 1.03
|
3.26 mm
Standard Deviation 0.81
|
SECONDARY outcome
Timeframe: Baseline to 3rd monthIt will be evaluated by taking periapical radiograph for canines before canine retraction and after 3 months period
Outcome measures
| Measure |
MOP Side
n=31 Participants
The Micro-osteoperforation side (The Intervention side)
|
Control Side
n=31 Participants
Non intervention side
|
|---|---|---|
|
Root Resorption
Root length at baseline
|
19.96 mm
Standard Deviation 2.2
|
19.66 mm
Standard Deviation 2.5
|
|
Root Resorption
Root length at 3 months
|
19.35 mm
Standard Deviation 2.0
|
18.93 mm
Standard Deviation 2.6
|
SECONDARY outcome
Timeframe: within 7 days after the interventionIt will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no pain and 10 = worst pain.
Outcome measures
| Measure |
MOP Side
n=32 Participants
The Micro-osteoperforation side (The Intervention side)
|
Control Side
n=32 Participants
Non intervention side
|
|---|---|---|
|
Pain Intensity
12 hour
|
2.6 units on a scale
Standard Deviation 2.79
|
1.6 units on a scale
Standard Deviation 2.35
|
|
Pain Intensity
Day 1
|
1.2 units on a scale
Standard Deviation 1.95
|
0.8 units on a scale
Standard Deviation 1.36
|
|
Pain Intensity
Day 3
|
0.8 units on a scale
Standard Deviation 1.41
|
0.6 units on a scale
Standard Deviation 1.29
|
|
Pain Intensity
Day 5
|
0.4 units on a scale
Standard Deviation 1.10
|
0.3 units on a scale
Standard Deviation 1.18
|
|
Pain Intensity
Day 7
|
0.2 units on a scale
Standard Deviation 0.71
|
0.3 units on a scale
Standard Deviation 1.28
|
|
Pain Intensity
Immediate
|
1.4 units on a scale
Standard Deviation 1.74
|
1.0 units on a scale
Standard Deviation 1.99
|
|
Pain Intensity
1 hour
|
2.4 units on a scale
Standard Deviation 2.15
|
1.5 units on a scale
Standard Deviation 2.23
|
SECONDARY outcome
Timeframe: within 7 days after the interventionIt will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no pain and 10 = worst pain.
Outcome measures
| Measure |
MOP Side
n=32 Participants
The Micro-osteoperforation side (The Intervention side)
|
Control Side
n=32 Participants
Non intervention side
|
|---|---|---|
|
Pain Interference /Pain During Eating?
Day 1
|
3.10 units on a scale
Standard Deviation 2.61
|
2.00 units on a scale
Standard Deviation 2.54
|
|
Pain Interference /Pain During Eating?
Day 3
|
1.03 units on a scale
Standard Deviation 1.58
|
0.65 units on a scale
Standard Deviation 1.23
|
|
Pain Interference /Pain During Eating?
Day 5
|
0.29 units on a scale
Standard Deviation 0.74
|
0.19 units on a scale
Standard Deviation 0.60
|
|
Pain Interference /Pain During Eating?
Day 7
|
0.13 units on a scale
Standard Deviation 0.56
|
0.10 units on a scale
Standard Deviation 0.54
|
SECONDARY outcome
Timeframe: within 7 days after the interventionIt will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no pain and 10 = worst pain.
Outcome measures
| Measure |
MOP Side
n=31 Participants
The Micro-osteoperforation side (The Intervention side)
|
Control Side
n=31 Participants
Non intervention side
|
|---|---|---|
|
Pain Interference /Pain Interrupted Sleep
Day 1
|
0.58 units on a scale
Standard Deviation 1.69
|
0.19 units on a scale
Standard Deviation 0.91
|
|
Pain Interference /Pain Interrupted Sleep
Day 3
|
0.13 units on a scale
Standard Deviation 0.56
|
0.03 units on a scale
Standard Deviation 0.18
|
|
Pain Interference /Pain Interrupted Sleep
Day 5
|
0.06 units on a scale
Standard Deviation 0.36
|
0.00 units on a scale
Standard Deviation 0.00
|
|
Pain Interference /Pain Interrupted Sleep
Day 7
|
0.00 units on a scale
Standard Deviation 0.00
|
0.00 units on a scale
Standard Deviation 0.00
|
SECONDARY outcome
Timeframe: within 7 days after the interventionIt will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no swelling and 10 = worst swelling.
Outcome measures
| Measure |
MOP Side
n=31 Participants
The Micro-osteoperforation side (The Intervention side)
|
Control Side
n=31 Participants
Non intervention side
|
|---|---|---|
|
Pain Interference /Swelling of the Surgical Side
Day 1
|
1.23 units on a scale
Standard Deviation 1.68
|
0.41 units on a scale
Standard Deviation 1.38
|
|
Pain Interference /Swelling of the Surgical Side
Day 3
|
0.48 units on a scale
Standard Deviation 1.18
|
0.26 units on a scale
Standard Deviation 1.26
|
|
Pain Interference /Swelling of the Surgical Side
Day 5
|
0.26 units on a scale
Standard Deviation 0.82
|
0.00 units on a scale
Standard Deviation 0.00
|
|
Pain Interference /Swelling of the Surgical Side
Day 7
|
0.06 units on a scale
Standard Deviation 0.25
|
0.00 units on a scale
Standard Deviation 0.00
|
SECONDARY outcome
Timeframe: within 7 days after the interventionIt will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = no discomfort and 10 = worst discomfort.
Outcome measures
| Measure |
MOP Side
n=31 Participants
The Micro-osteoperforation side (The Intervention side)
|
Control Side
n=31 Participants
Non intervention side
|
|---|---|---|
|
Pain Interference /Discomfort
Day 1
|
2.10 units on a scale
Standard Deviation 2.52
|
1.29 units on a scale
Standard Deviation 2.19
|
|
Pain Interference /Discomfort
Day 3
|
0.77 units on a scale
Standard Deviation 1.36
|
0.58 units on a scale
Standard Deviation 1.29
|
|
Pain Interference /Discomfort
Day 5
|
0.23 units on a scale
Standard Deviation 0.56
|
0.10 units on a scale
Standard Deviation 0.40
|
|
Pain Interference /Discomfort
Day 7
|
0.06 units on a scale
Standard Deviation 0.25
|
0.03 units on a scale
Standard Deviation 0.18
|
SECONDARY outcome
Timeframe: After 7 days of MOP applicationIt will be evaluated by using Visual Analog Scale (VAS) from 0 to 10 Numeric Rate Scale in which 0 = unsatisfied and 10 = most satisfaction.
Outcome measures
| Measure |
MOP Side
n=32 Participants
The Micro-osteoperforation side (The Intervention side)
|
Control Side
Non intervention side
|
|---|---|---|
|
Patient Satisfaction
|
8.94 units on a scale
Standard Deviation 1.35
|
—
|
SECONDARY outcome
Timeframe: within 3 monthsPopulation: Sufficient data were not collected from any participant
the relationship between the rate of tooth movement and Menstrual cycle
Outcome measures
Outcome data not reported
Adverse Events
MOP Side
Control Side
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr.Amal Alkebsi
Jordanian University of science and Technology
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place